LGND – Ligand Pharmaceuticals Incorporated

Name :

Sector :

Industry:

Mark. Cap: $0.0000

EPSttm :

Float Short %

5.15

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.5

EPS Last/This Y

EPS This/Next Y

0.49

Price

120.51

Target Price

142.38

Analyst Recom

1.14

Performance Q

8.06

Relative Volume

1.31

Beta

1.16

Ticker: LGND

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	LGND	115.13	0.18	0.14	911
2025-01-24	LGND	115.06	0.17	0.00	914
2025-01-27	LGND	117.39	0.17	0.00	922
2025-01-28	LGND	118.3	0.17	0.00	914
2025-01-29	LGND	119.08	0.17	2.00	926
2025-01-30	LGND	118.58	0.18	0.10	920
2025-01-31	LGND	116.25	0.18	0.00	919
2025-02-03	LGND	114.54	0.18	0.00	931
2025-02-04	LGND	117.45	0.18	0.67	933
2025-02-05	LGND	117.35	0.18	0.00	935
2025-02-06	LGND	117.47	0.18	0.00	936
2025-02-07	LGND	115.22	0.18	0.00	935
2025-02-10	LGND	114.31	0.18	0.00	945
2025-02-11	LGND	112.79	0.18	0.00	955
2025-02-12	LGND	111.2	0.18	0.00	954
2025-02-13	LGND	114.36	0.18	5.00	950
2025-02-14	LGND	120.02	0.17	0.00	943
2025-02-18	LGND	119.94	0.16	0.27	955
2025-02-19	LGND	122.15	0.17	0.00	968
2025-02-20	LGND	122.03	0.16	0.00	988
2025-02-21	LGND	120.68	0.16	0.26	984
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	LGND	115.38	-13.8	21.3	5.64
2025-01-24	LGND	115.31	-13.8	21.6	5.64
2025-01-27	LGND	117.30	-13.8	23.5	5.64
2025-01-28	LGND	118.32	-13.8	22.5	5.64
2025-01-29	LGND	118.92	-13.8	22.3	5.64
2025-01-30	LGND	118.64	-13.8	21.5	5.64
2025-01-31	LGND	116.46	-13.8	20.0	5.64
2025-02-03	LGND	114.76	-13.8	20.3	5.64
2025-02-04	LGND	117.26	-13.8	23.7	5.64
2025-02-05	LGND	117.32	-13.8	21.2	5.64
2025-02-06	LGND	117.45	-13.8	21.8	5.64
2025-02-07	LGND	115.22	-13.8	19.7	5.64
2025-02-10	LGND	114.12	-13.8	20.8	5.64
2025-02-11	LGND	112.80	-13.8	20.6	5.64
2025-02-12	LGND	111.14	-13.8	20.3	5.64
2025-02-13	LGND	113.93	-13.8	23.8	5.64
2025-02-14	LGND	120.00	-13.8	26.6	5.64
2025-02-18	LGND	119.86	-13.8	21.6	5.64
2025-02-19	LGND	122.00	-13.8	23.2	5.64
2025-02-20	LGND	122.18	-13.8	21.8	5.64
2025-02-21	LGND	120.51	-13.8	20.6	5.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	LGND	-12.50	4.89	4.87
2025-01-24	LGND	-12.50	4.89	4.87
2025-01-27	LGND	-12.50	4.89	4.87
2025-01-28	LGND	-12.50	4.89	4.93
2025-01-29	LGND	-12.50	4.89	4.93
2025-01-30	LGND	-12.50	4.89	4.93
2025-01-31	LGND	-12.50	4.89	4.93
2025-02-03	LGND	-12.50	4.04	4.93
2025-02-04	LGND	-12.50	4.04	4.93
2025-02-05	LGND	-12.50	4.04	4.93
2025-02-06	LGND	-12.50	4.04	4.93
2025-02-07	LGND	-12.50	4.04	4.93
2025-02-10	LGND	-12.96	2.33	4.94
2025-02-11	LGND	-12.42	2.33	4.94
2025-02-12	LGND	-12.42	2.33	5.16
2025-02-13	LGND	-12.42	2.33	5.16
2025-02-14	LGND	-9.45	2.33	5.15
2025-02-18	LGND	-9.45	-0.18	5.15
2025-02-19	LGND	-9.45	-0.18	5.15
2025-02-20	LGND	-9.45	-0.18	5.15
2025-02-21	LGND	-9.45	-0.18	5.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.84

Avg. EPS Est. Current Quarter

1.18

Avg. EPS Est. Next Quarter

1.34

Insider Transactions

-9.45

Institutional Transactions

-0.18

Beta

1.16

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

158.52

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-65.5

Target Price

142.38

P/E

48.01

Forward P/E

19.89

PEG

13.23

P/S

14.96

P/B

2.69

P/Free Cash Flow

30.87

EPS

2.51

Average EPS Est. Cur. Y

5.64

EPS Next Y. (Est.)

6.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.68

Relative Volume

1.31

Return on Equity vs Sector %

-13.9

Return on Equity vs Industry %

1.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

20.6

stock quote shares LGND – Ligand Pharmaceuticals Incorporated Stock Price stock today

news today LGND – Ligand Pharmaceuticals Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch LGND – Ligand Pharmaceuticals Incorporated yahoo finance google finance

stock history LGND – Ligand Pharmaceuticals Incorporated invest stock market

stock prices LGND premarket after hours

ticker LGND fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

LGND – Ligand Pharmaceuticals Incorporated

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: LGND

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y